- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.55 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: K.106, N.107, N.189, K.191
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 10 residues within 4Å:- Chain A: Y.478, N.480, N.482, E.483, T.484, Q.485
- Chain B: C.67, D.88, L.89, Q.271
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:L.89, B:L.89
NAG-NAG.6: 6 residues within 4Å:- Chain B: Y.238, N.242, N.246, P.282, Y.283
- Ligands: FUL.21
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Y.283
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.8: 3 residues within 4Å:- Chain A: I.5, N.18, T.25
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:N.18
NAG.9: 2 residues within 4Å:- Chain A: S.339, N.342
1 PLIP interactions:1 interactions with chain A- Water bridges: A:G.337
NAG.18: 2 residues within 4Å:- Chain B: I.5, N.18
No protein-ligand interaction detected (PLIP)NAG.19: 2 residues within 4Å:- Chain B: R.15, N.58
No protein-ligand interaction detected (PLIP)NAG.20: 2 residues within 4Å:- Chain B: N.107, N.189
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.189
NAG.22: 2 residues within 4Å:- Chain B: N.257, E.260
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.257
NAG.23: 4 residues within 4Å:- Chain B: G.337, S.339, N.342, N.343
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:G.337, B:S.339
- Water bridges: B:G.337
NAG.24: 4 residues within 4Å:- Chain B: Y.478, N.482, E.483, T.484
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.482
- 2 x 5HB: N-{[(3R)-1-benzylpiperidin-3-yl]methyl}-N-methylnaphthalene-2-sulfonamide(Non-covalent)
5HB.10: 18 residues within 4Å:- Chain A: W.83, G.117, G.118, Q.120, T.121, S.199, W.232, L.287, S.288, A.329, F.330, Y.333, F.399, W.431, M.438, H.439, Y.441
- Ligands: UNX.16
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:A.329, A:F.330, A:Y.333, A:F.399, A:W.431, A:Y.441
- Hydrogen bonds: A:T.121
- Salt bridges: A:D.71
- pi-Stacking: A:W.83, A:W.232, A:W.232, A:F.330
5HB.25: 19 residues within 4Å:- Chain B: W.83, G.117, G.118, Q.120, T.121, S.199, W.232, L.287, S.288, V.289, A.329, F.330, Y.333, F.399, W.431, M.438, H.439, Y.441
- Ligands: UNX.32
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:W.232, B:V.289, B:A.329, B:F.330, B:Y.333, B:Y.333, B:F.399, B:W.431, B:Y.441
- Hydrogen bonds: B:T.121
- Salt bridges: B:D.71
- pi-Stacking: B:W.83, B:F.330
- 5 x GOL: GLYCEROL(Non-functional Binders)
GOL.11: 5 residues within 4Å:- Chain A: L.19, Y.62, W.99, D.130, K.132
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:W.99, A:K.132, A:K.132
GOL.12: 7 residues within 4Å:- Chain A: N.229, Y.397, C.401, P.402, E.405, W.523, T.524
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.229
GOL.13: 6 residues within 4Å:- Chain A: Y.34, S.49, L.50, L.174, Q.177, W.178
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.49, A:L.50
- Water bridges: A:N.182
GOL.26: 5 residues within 4Å:- Chain B: L.19, Y.62, W.99, D.130, K.132
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:W.99, B:K.132
GOL.27: 8 residues within 4Å:- Chain B: P.231, W.232, T.285, L.287, S.288, V.289, N.398
- Ligands: EDO.29
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:T.285, B:V.289, B:N.398
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.14: 4 residues within 4Å:- Chain A: H.78, M.82, K.428, E.444
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.428
EDO.28: 4 residues within 4Å:- Chain B: R.43, R.266, K.268, P.270
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.43, B:K.268
- Water bridges: B:G.40, B:E.91
EDO.29: 8 residues within 4Å:- Chain B: P.231, W.232, V.234, T.235, E.239, R.243, V.289
- Ligands: GOL.27
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:P.231, B:V.289
EDO.30: 1 residues within 4Å:- Chain B: N.456
No protein-ligand interaction detected (PLIP)- 6 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
UNX.15: 5 residues within 4Å:- Chain A: G.116, G.117, E.198
- Ligands: UNX.16, UNX.17
No protein-ligand interaction detected (PLIP)UNX.16: 3 residues within 4Å:- Ligands: 5HB.10, UNX.15, UNX.17
No protein-ligand interaction detected (PLIP)UNX.17: 5 residues within 4Å:- Chain A: G.117, E.198, S.199
- Ligands: UNX.15, UNX.16
No protein-ligand interaction detected (PLIP)UNX.31: 3 residues within 4Å:- Chain B: E.198
- Ligands: UNX.32, UNX.33
No protein-ligand interaction detected (PLIP)UNX.32: 4 residues within 4Å:- Chain B: W.83
- Ligands: 5HB.25, UNX.31, UNX.33
No protein-ligand interaction detected (PLIP)UNX.33: 6 residues within 4Å:- Chain B: W.83, G.116, G.117, E.198
- Ligands: UNX.31, UNX.32
No protein-ligand interaction detected (PLIP)- 1 x FUL: beta-L-fucopyranose(Non-covalent)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kosak, U. et al., Development of an in-vivo active reversible butyrylcholinesterase inhibitor. Sci Rep (2016)
- Release Date
- 2016-10-05
- Peptides
- Cholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.55 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x 5HB: N-{[(3R)-1-benzylpiperidin-3-yl]methyl}-N-methylnaphthalene-2-sulfonamide(Non-covalent)
- 5 x GOL: GLYCEROL(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 6 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
- 1 x FUL: beta-L-fucopyranose(Non-covalent)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kosak, U. et al., Development of an in-vivo active reversible butyrylcholinesterase inhibitor. Sci Rep (2016)
- Release Date
- 2016-10-05
- Peptides
- Cholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B